Related Experiment Video

Updated: May 20, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

The diagnostic utility of cardiac biomarkers in dialysis patients

Angela Yee-Moon Wang1, Christopher Wai-Kei Lam

  • 1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong. aymwang@hku.hk

Seminars in Dialysis
|July 4, 2012
PubMed

Insights

High mortality in dialysis patients is linked to cardiovascular disease. Serum cardiac biomarkers like cardiac troponin and natriuretic peptides show promise for predicting cardiovascular risk and improving patient outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomarkers

Background:

  • Dialysis patients face high cardiovascular disease (CVD) burden, including coronary artery disease, left ventricular hypertrophy, and heart failure.
  • Effective cardiovascular risk stratification is crucial for managing dialysis patients and optimizing interventions to reduce morbidity and mortality.

Purpose of the Study:

  • To review the diagnostic potential and clinical applications of serum cardiac biomarkers for cardiovascular risk prediction in the dialysis population.
  • To explore the utility of cardiac troponin and natriuretic peptides as prognostic markers in dialysis patients.

Main Methods:

  • Review of current literature on cardiac biomarkers in the dialysis population.
  • Analysis of the diagnostic and prognostic capabilities of cardiac troponin and natriuretic peptides.

Main Results:

  • Cardiac troponin is a sensitive and specific marker for myocardial damage, crucial for acute myocardial infarction diagnosis.
  • Natriuretic peptides indicate heart failure and left ventricular wall stress, emerging as key diagnostic markers.
  • Both biomarkers reflect unique myocardial pathologies and are powerful prognostic indicators in dialysis patients.

Conclusions:

  • Serum cardiac biomarkers, specifically cardiac troponin and natriuretic peptides, hold significant potential for cardiovascular risk prediction and stratification in dialysis patients.
  • These biomarkers can aid in early identification of high-risk individuals, facilitating optimized therapeutic strategies.
  • Further clinical application of these biomarkers may lead to improved cardiovascular outcomes in the dialysis population.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...